Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well therapeutic angiotensin-(1-7) works as second-line
therapy or third-line therapy in treating patients with metastatic sarcoma that cannot be
removed by surgery. Therapeutic angiotensin-(1-7) may stop the growth of sarcoma by blocking
blood flow to the tumor.
Funding Source - FDA Office of Orphan Drug Products (OOPD)